Evidence map›Paper›PMID 40186259›Full record

ArticleJournal of nanobiotechnology2025

Platycodon grandiflorum exosome-like nanoparticles: the material basis of fresh platycodon grandiflorum optimality and its mechanism in regulating acute lung injury.

Jingmin Fu, Zhuolin Liu, Zhiying Feng, Jiawang Huang, Jianing Shi, Kangyu Wang, Xuelian Jiang, Jiaxin Yang, Yi Ning, Fangguo Lu and 1 more

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Protective Effects of Orally AdministeredInternational journal of nanomedicine · 2026
    Article
  18. Review
  19. Extracellular vesicles and circulating nucleic acids · 2026
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jingmin Fu *College of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Xueshi 300 Road, Changsha, Hunan, 410208, PR China.
Zhuolin Liu *College of Integrated Traditional Chinese and Western Medicine, Hunan University of Chinese Medicine, Xueshi Road 300, Changsha, Hunan, 410208, PR China.
Zhiying Feng *College of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Xueshi 300 Road, Changsha, Hunan, 410208, PR China.
Jiawang HuangCollege of Integrated Traditional Chinese and Western Medicine, Hunan University of Chinese Medicine, Xueshi Road 300, Changsha, Hunan, 410208, PR China.
Jianing ShiCollege of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Xueshi 300 Road, Changsha, Hunan, 410208, PR China.
Kangyu WangCollege of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Xueshi 300 Road, Changsha, Hunan, 410208, PR China.
Xuelian JiangCollege of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Xueshi 300 Road, Changsha, Hunan, 410208, PR China.
Jiaxin YangCollege of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Xueshi 300 Road, Changsha, Hunan, 410208, PR China.
Yi NingThe Medicine School, Hunan University of Chinese Medicine, Xueshi Road 300, Changsha, Hunan, 410208, PR China. 004217@hnucm.edu.cn.
Fangguo LuThe Medicine School, Hunan University of Chinese Medicine, Xueshi Road 300, Changsha, Hunan, 410208, PR China. 001196@hnucm.edu.cn.
Ling LiCollege of Integrated Traditional Chinese and Western Medicine, Hunan University of Chinese Medicine, Xueshi Road 300, Changsha, Hunan, 410208, PR China. liling1049@hnucm.edu.cn.

Funding

Excellent Youth Project of Hunan Provincial Department of Education 23B0379Key Projects of Traditional Chinese Medicine Research in Hunan Province A2024010National College Student Innovation and Entrepreneurship Training Program S202410541014National Natural Science Foundation of China 81973670National Natural Science Foundation of China 82374266Natural Science Foundation of Hunan Province 2023JJ10031Outstanding Innovative Youth Project of Changsha kq2209019
6 · The paper itself

Abstract

backgroundAcute lung injury (ALI) is a severe respiratory disease accompanied by diffuse inflammatory responses induced by various clinical causes. Many fresh medicinal plants have shown better efficacy than their dried forms in preventing and treating diseases like inflammation. As a classical Chinese herb, platycodon grandiflorum (PG) has been demonstrated effective in treating pneumonia, but most of previous studies focused on the efficacy of processed or dried PG formats, while the specific benefits of its fresh form are still underexplored. Exosome-like nanoparticles derived from medicinal plants are expected to point out an important direction for exploring the material basis and mechanism of this fresh herbal medicine.

resultsThe fresh form of PG could effectively improve ALI induced by lipopolysaccharide (LPS), relieve lung histopathological injury and weight loss, and reduce levels of inflammatory factors in mice, exhibiting better efficacy than dried PG in the treatment of ALI. Further extraction and purification of PG exosome-like nanoparticles (PGLNs) demonstrated that PGLNs had good biocompatibility, with characteristics consistent with general exosome-like nanoparticles. Besides, proteomic analysis indicated that PGLNs were rich in a variety of proteins. Animal experiments showed that PGLNs improved the pathological changes in LPS-induced lung tissues, inhibited the expression of inflammatory factors and promoted the expression of anti-inflammatory factors, and exerted a regulatory effect on the polarization of lung macrophages. Cell experiments further confirmed that PGLNs could be effectively taken up by RAW264.7 cells and repolarize M1 macrophages into M2 type, therefore reducing the secretion of harmful cytokines. Moreover, non-targeted metabolomics analysis reveals that PGLNs reduce inflammation and control macrophage polarization in a manner closely linked to pathways including glycolysis and lipid metabolism, highlighting a potential mechanism by which PGLNs protect the lungs from inflammatory damage like ALI.

conclusionFresh PG has better anti-inflammatory and repair effects than its dried form. As one of the most effective active substances in fresh PG, PGLNs may regulate macrophage inflammation and polarization by regulating metabolic pathways including lipid metabolism and glycolysis, so as to reduce inflammation and repair lung injury.

Indexed as

Acute Lung InjuryExosomesNanoparticlesPlant ExtractsPlatycodonAnimalsLipopolysaccharidesLungMaleMiceMice, Inbred C57BLProteomicsRAW 264.7 CellsLipopolysaccharidesPlant ExtractsAcute lung injuryFresh medicinal plantMacrophage polarizationNon-targeted metabolomicsPGLNsPlatycodon grandiflorum

Identifiers

PMID40186259
PMCPMC11969861

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.